Checkpoint-Inhibitor wirksam bei CCR und Magenkarzinom

被引：0
|
作者：
Thomas Riedel
机构：
来源：
Gastro-News | 2018年 / 5卷 / 1期
关键词：
D O I：
10.1007/s15036-018-0336-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：49 / 49
相关论文
共 50 条
  • [31] Feasibility of exercise as a supportive measure for patients undergoing checkpoint-inhibitor treatment: A randomized controlled trail
    Mueller, Jana
    Rosenberger, Friederike
    Hassel, Jessica Cecile
    Wiskemann, Joachim
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 213 - 213
  • [32] Glycoproteomics-based liquid biopsy informs optimal checkpoint-inhibitor drug choice
    Lindpaintner, Klaus
    Xu, Gege
    Rice, Rachel
    Mitchell, Alan
    Frederick, Dennie
    Boland, Genevieve
    Seie, Daniel
    CANCER RESEARCH, 2022, 82 (12)
  • [33] JAK-Inhibitor - wirksam und sicher im Vergleich der Therapieoption
    Wiebke Kathmann
    Gastro-News, 2022, 9 (3) : 58 - 58
  • [34] Histological features of cutaneous toxicity with checkpoint-inhibitor immunotherapy for metastatic melanoma: a retrospective case series
    Kawsar, A.
    Patel, P.
    Markiewicz, D.
    Szlosarek, P.
    Phillips, M.
    Harwood, C.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 117 - 117
  • [35] Wie wirksam sind Probiotika bei Reizdarm, CED und C.-difficile-Infektionen?
    Justus Franz Toader
    Andreas Erhardt
    Gastro-News, 2023, 10 (3) : 40 - 45
  • [36] Who is the Culprit in this Diagnostic Case Challenge of Pneumonitis: COVID-19, or immune checkpoint-inhibitor?
    Lim, Anthony M.
    Thukral, Jatin
    Kaur, Harbir
    Siddiqi, Sarosh
    Oberndorf, Julia
    Ghazaleh, Jonathan
    Cacdac, Robert
    Quizon, Marrey
    JOURNAL OF INVESTIGATIVE MEDICINE, 2024, 72 (01)
  • [37] Glycoproteomics as a powerful liquid biopsy-based predictor of checkpoint-inhibitor treatment response.
    Xu, Gege
    Rice, Rachel
    Huang, Hector
    Lindpaintner, Klaus
    Prendergast, Jillian M.
    Normington, Karl
    Frederick, Dennie
    Boland, Genevieve M.
    Serie, Daniel
    CANCER RESEARCH, 2021, 81 (13)
  • [38] Glycoproteomics-based liquid biopsy identifies checkpoint-inhibitor responders and informs optimal drug choice
    Mitchell, Alan
    Xu, Gege
    Rice, Rachel
    Lindpaintner, Klaus
    Frederick, Dennie
    Boland, Genevieve
    Serie, Daniel
    GLYCOBIOLOGY, 2021, 31 (12) : 1687 - 1688
  • [39] Poliosis Is Associated with Response to Checkpoint-Inhibitor Therapy: A Case Report of Two Patients with Multifocal Metastatic Melanoma
    Haist, Maximilian
    Stege, Henner
    Maikranz, Verena
    Halley Blanco, Maria
    Grabbe, Stephan
    Loquai, Carmen
    IMMUNO, 2022, 2 (02): : 307 - 316
  • [40] ASSOCIATION BETWEEN PEAK EOSINOPHIL COUNTS AND CHECKPOINT-INHIBITOR PNEUMONITIS IN PATIENTS WITH ADVANCED PRIMARY LUNG CANCER
    Husain, Abdurrahman
    Siddiqi, Muhammad
    Patel, Sandip
    Montgrain, Philippe
    Akuthota, Praveen
    CHEST, 2021, 160 (04) : 1606A - 1607A
12345